Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-02-26 | New | $70,000 | $70,000 | Debt Only | 06b | SEC link |
| 2016-02-19 | Amended | $2,513,413 | $355,000 | Equity Only | 06c | SEC link |
| 2016-02-04 | New | $2,000,000 | $2,000,000 | Equity Only | 06b | SEC link |
| 2015-10-30 | Amended | $2,158,413 | $121,399 | Equity Only | 06c | SEC link |
| 2015-09-22 | New | $2,037,014 | $2,037,014 | Equity Only | 06c | SEC link |
| Name | Role |
|---|---|
| Jonathan Cohen | Director, Executive |
| Richard M. Cohen | Director |
| John G Compton | Director |
| Dean Hautamaki | Director |
| Michael Hertzberg | Director |
| Joel Kanter | Director, Executive |
| Vladimir Knezevic | Director |
| Wei Lu | Director |
| Caroline Popper | Director |
| Prasanth Reddy | Director |
| John W. Rollins | Director |
| Michael A Ross | Director |
| Anne Shiflett | Executive |
| Larry Shulman | Director |
| Donald Wallach | Director |
| Jiminy Zhou | Executive |